Skip to main content

NBS1 Mutation and prognosis of prostate cancer

Inherited factors contribute to the burden of prostate cancer, however the identification of susceptibility genes for prostate caner has been challenging. To establish the contribution of eight founder alleles in three DNA damage repair genes (BRCA1, CHEK2 and NBS1) to prostate cancer in Poland, and to measure the impact of these variants on survival among patients, 3750 men with prostate cancer and 3956 cancer-free controls were genotyped for 3 founder alleles in BRCA1 (5382insC, 4153delA, C61G), 4 alleles in CHEK2 (1100delC, IVS2+1G>A, del5395, I157T), and 1 allele in NBS1 (657del5). Strong associations were seen for both CHEK2 and NBS1. BRCA1 was not associated with the risk of prostate cancer, NBS1 mutation was associated with poor survival - mortality was significantly worse for carriers of a NBS1 mutation than for non-carriers (HR = 1.85; p = 0.008). We conclude that a founder mutation in NBS1 predisposes to aggressive prostate cancer.

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Wokołorczyk, D., Kluźniak, W., Cybulski, C. et al. NBS1 Mutation and prognosis of prostate cancer. Hered Cancer Clin Pract 10 (Suppl 4), A29 (2012).

Download citation

  • Published:

  • DOI:


  • Public Health
  • Prostate Cancer
  • Cancer Research
  • Strong Association
  • Poor Survival